Targeted therapies for advanced/metastatic renal cell carcinoma (mRCC) – Certificate of Completion
Australie
$0
gratuit
Certificate of Completion
Anglais
3 Credits
Description du cours
Détails du cours
Date d'expiration : 2017-06-25
Métiers: Médecin
Faculté
Accréditation
Objectif(s) d'apprentissage
After completing this module, participants will have an enhanced understanding of:
- the rapidly evolving landscape of advanced/metastatic renal cell carcinoma (mRCC) therapy, including review of:
- mechanisms of action of signal transduction inhibitors
- clinical trial evidence for standard of care treatment of different categories of advanced RCC patients
- indications, contra-indications, side effect profiles and current Pharmaceutical Benefits Scheme (PBS) listing of reimbursed targeted therapies for advanced/metastatic RCC